Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Lithuania
Lithuania: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 87.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Lithuania, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Lithuania is 87.0%, measured in 2025. That is the highest value across all 18 years on record.
The figure is up 4.8% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Lithuania peaked at 87.0% in 2024 and was at its lowest, 0.0%, in 2008.
That places Lithuania 86th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 32.9% | 0.0% | 83.0% | 10 |
| 2020s | 83.7% | 81.0% | 87.0% | 6 |
Countries ranked near Lithuania
- 86 Kenya 87.0% compare
- 86 Kiribati 87.0% compare
- 86 Dominican Republic 87.0% compare
- 86 Netherlands 87.0% compare
- 86 Niger 87.0% compare
More health data for Lithuania
- Heat deaths vs projected death rates 1,909 (2090)
- Un projection of annual infant deaths 5 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 17,494 (2025)
- Age population, age 25, female, interpolated 16,722 (2025)
- Age population, age 24, male, interpolated 16,310 (2025)
- Age population, age 24, female, interpolated 15,742 (2025)
- Age population, age 23, male, interpolated 15,317 (2025)
- Age population, age 23, female, interpolated 14,833 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Lithuania?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Lithuania was 87.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Lithuania?
- The highest recorded value was 87.0% in 2024.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Lithuania?
- The lowest recorded value was 0.0% in 2008.
- How does Lithuania rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Lithuania ranks 86th out of 194 countries with data for 2025.
- Where does this Lithuania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).